Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Balvinder S. Shoker"'
Autor:
Dong Liu Barraclough, Susan Sewart, Philip S. Rudland, Balvinder S. Shoker, D. Ross Sibson, Roger Barraclough, Michael P. A. Davies
Publikováno v:
Cellular Oncology, Vol 32, Iss 1-2, Pp 87-99 (2010)
Background: A major challenge of cancer research is to identify key molecules which are responsible for the development of the malignant metastatic phenotype, the major cause of cancer death.
Externí odkaz:
https://doaj.org/article/b0c6663e10d14ed89bb7f1a157e42114
Autor:
Chris Holcombe, John P. Sloane, Balvinder S. Shoker, Nee Beng Teo, Christine Jarvis, L Martin
Publikováno v:
British Journal of Cancer
Up to 50% of recurrences of ductal carcinoma in situ of the breast are associated with invasive carcinoma but no pathological or molecular features have yet been found to predict for the development of invasive disease. For a tumour to invade, it req
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::218e384378161d8681b6484c241e9d8c
https://doi.org/10.1038/sj.bjc.6600053
https://doi.org/10.1038/sj.bjc.6600053
Autor:
John P. Sloane, Balvinder S. Shoker, Michael P.A. Davies, Christine Jarvis, Mussawar Iqbal, D. Ross Sibson
Publikováno v:
The Journal of Pathology. 193:333-338
In normal breast, there is a negative association between expression of oestrogen receptor (ER) and the proliferation marker Ki67, indicating that ER-positive (ER+) cells do not divide, or that the receptor is down-regulated when they do so. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b6e1c1e225ba4cb6c851f459401bff7
https://doi.org/10.1002/1096-9896(2000)9999:9999<::aid-path801>3.0.co
https://doi.org/10.1002/1096-9896(2000)9999:9999<::aid-path801>3.0.co
Publikováno v:
The Journal of Pathology. 188:237-244
As oestrogen is associated with most of the epidemiological risk factors for breast cancer, the number and distribution of oestrogen receptor positive (ER+) cells could have a bearing on the development of the disease. ER+ cells were thus studied in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a2045f3df4dff941b9074ec8be16e89
https://doi.org/10.1002/(sici)1096-9896(199907)188:3<237::aid-path343>3.0.co
https://doi.org/10.1002/(sici)1096-9896(199907)188:3<237::aid-path343>3.0.co
Thymidine phosphorylase expression and stromal vascularity in ductal carcinoma in situ of the breast
Publikováno v:
Journal of clinical pathology. 56(12)
Aims: Periductal angiogenesis in ductal carcinoma in situ is associated with an increased risk of subsequently developing a recurrence. This study aimed to (1) identify the relation between periductal and stromal vascularity and recurrence and (2) de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5ae3f91b91fbccf3eec13e0462d2439
https://pubmed.ncbi.nlm.nih.gov/14645350
https://pubmed.ncbi.nlm.nih.gov/14645350
Autor:
L Martin, Christopher Holcombe, John P. Sloane, Nee Beng Teo, Christine Jarvis, Balvinder S. Shoker
Publikováno v:
European journal of cancer (Oxford, England : 1990). 39(1)
The development of an invasive recurrence following treatment for ductal carcinoma in situ (DCIS) converts a non-fatal disease to one associated with mortality. To date, no pathological or molecular features have been found to predict for the type of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4eacc75cf1fd1ea0f9f3f6885cbe7e8
https://pubmed.ncbi.nlm.nih.gov/12504656
https://pubmed.ncbi.nlm.nih.gov/12504656
Autor:
Mussawar Iqbal, Christopher S. Foster, Christine Jarvis, D. Ross Sibson, Balvinder S. Shoker, Michael P.A. Davies
Publikováno v:
Human pathology. 33(7)
Hyperplasia of usual type (HUT) may be an early precursor of breast carcinoma and has been shown to contain molecular and genetic abnormalities previously seen in more advanced breast lesions, such as allelic imbalance (AI) and coexpression of estrog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca429607ad11a751c2166d3620fa2463
https://pubmed.ncbi.nlm.nih.gov/12196923
https://pubmed.ncbi.nlm.nih.gov/12196923
Publikováno v:
Anticancer research. 22(4)
To date, research in the role of angiogenesis in cancer has focused mainly on invasive diseases. Measurement of the intra-tumoural microvessel density (MVD) has also been found to be an independent prognostic marker. More recently, natural angiogenic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5656792f1533495abb1750908718b43e
https://pubmed.ncbi.nlm.nih.gov/12174884
https://pubmed.ncbi.nlm.nih.gov/12174884
Autor:
John P. Sloane, D R Sibson, Balvinder S. Shoker, Michael P.A. Davies, Elizabeth Anderson, Christine Jarvis, C Munro, Robert Clarke
Background —In normal breast tissue the oestrogen receptor (ER) and the proliferation associated antigen Ki67 are negatively associated, indicating that ER+ cells are non-dividing, or that the receptor is downregulated as cells enter cycle. This re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2a18f5d24030a0841dccbdbe06d0489
https://europepmc.org/articles/PMC1731078/
https://europepmc.org/articles/PMC1731078/
Autor:
Balvinder S. Shoker, Michael P.A. Davies, Christine Jarvis, Joanne Hewlett, John P. Sloane, Elizabeth Anderson, D. Ross Sibson, Robert Clarke
Recently it has been shown that epithelial cell expression of the estrogen receptor (ER) and that of the proliferation-associated marker Ki-67 are almost mutually exclusive in the normal premenopausal human breast but that coexpression frequently occ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f488093ea4feb99ca0d92c85d1d998d8
https://europepmc.org/articles/PMC1866935/
https://europepmc.org/articles/PMC1866935/